Found 11 results. Export: Tagged | XML
Filters: keyword is Antiparkinson Agents  [Clear All Filters]
2008
Ravenstijn, P.G., Merlini, M., Hameetman, M., Murray, T.K., Ward, M.A., Lewis, H., Ball, G., Mottart, C., de Ville Goyet, C., Lemarchand, T., van Belle, K., O'Neill, M.J., Danhof, M., de Lange, E.C. , The exploration of rotenone as a toxin for inducing Parkinson's disease in rats, for application in BBB transport and PK-PD experiments, J Pharmacol Toxicol Methods, vol. 57, no. 2, pp. 114-30. DOI
2004
Nugroho, A.K., Li, G.L., Danhof, M., Bouwstra, J.A. , Transdermal iontophoresis of rotigotine across human stratum corneum in vitro: influence of pH and NaCl concentration, Pharm Res, vol. 21, no. 5, pp. 844-50.
2001
Li, G.L., Danhof, M., Bouwstra, J.A. , Lontophoretic delivery of apomorphine in vitro: physicochemic considerations, Pharm Res, vol. 18, no. 11, pp. 1509-13.
1999
van Laar, T., Van der Geest, R., Danhof, M. , Future delivery systems for apomorphine in patients with Parkinson's disease, Adv Neurol, vol. 80, pp. 535-44.
1998
van der Geest, R., van Laar, T., Kruger, P.P., Gubbens-Stibbe, J.M., Bodde, H.E., Roos, R.A., Danhof, M. , Pharmacokinetics, enantiomer interconversion, and metabolism of R-apomorphine in patients with idiopathic Parkinson's disease, Clin Neuropharmacol, vol. 21, no. 3, pp. 159-68.
van Laar, T., van der Geest, R., Danhof, M., Bodde, H.E., Goossens, P.H., Roos, R.A. , Stepwise intravenous infusion of apomorphine to determine the therapeutic window in patients with Parkinson's disease, Clin Neuropharmacol, vol. 21, no. 3, pp. 152-8.
1997
van der Geest, R., Kruger, P., Gubbens-Stibbe, J.M., van Laar, T., Bodde, H.E., Danhof, M. , Assay of R-apomorphine, S-apomorphine, apocodeine, isoapocodeine and their glucuronide and sulfate conjugates in plasma and urine of patients with Parkinson's disease, J Chromatogr B Biomed Sci Appl, vol. 702, no. 1-2, pp. 131-41.
van der Geest, R., Danhof, M., Bodde, H.E. , Iontophoretic delivery of apomorphine. I: In vitro optimization and validation, Pharm Res, vol. 14, no. 12, pp. 1798-803.
van der Geest, R., van Laar, T., Gubbens-Stibbe, J.M., Bodde, H.E., Danhof, M. , Iontophoretic delivery of apomorphine. II: An in vivo study in patients with Parkinson's disease, Pharm Res, vol. 14, no. 12, pp. 1804-10.
1996
van Laar, T., Neef, C., Danhof, M., Roon, K. I, Roos, R.A. , A new sublingual formulation of apomorphine in the treatment of patients with Parkinson's disease, Mov Disord, vol. 11, no. 6, pp. 633-8. DOI
1995
van Laar, T., Jansen, E.N., Neef, C., Danhof, M., Roos, R.A. , Pharmacokinetics and clinical efficacy of rectal apomorphine in patients with Parkinson's disease: a study of five different suppositories, Mov Disord, vol. 10, no. 4, pp. 433-9. DOI